CDRT4 (CMT1A duplicated region transcript 4) is a nuclear-localized RNA transcript with emerging roles in cellular regulation and disease processes. Functionally, CDRT4 exhibits semi-extractable properties consistent with phase-separated membraneless organelles, localizing to nuclear compartments while remaining dissociated from chr17 1. The transcript participates in RNA-RNA interaction networks and likely functions within nuclear regulatory bodies 1. Mechanistically, CDRT4 plays a critical role in mitochondrial ROS regulation and cellular senescence. Knockdown of TVP23C-CDRT4 reduces mitochondrial reactive oxygen species generation and restores senescence-associated phenotypes, suggesting CDRT4 negatively regulates ROS production 2. Additionally, CDRT4 is part of a fusion transcript (TVP23C-CDRT4) that is highly expressed in adenoid cystic carcinoma tissues 3. Disease relevance spans multiple malignancies: the TVP23C-CDRT4 fusion was detected in 3 adenoid cystic carcinoma tissues and represents a novel oncogenic fusion 3. In triple-negative breast cancer, CDRT4 is upregulated following combined JQ1-GSK2801 treatment, indicating involvement in therapeutic response pathways 4. Clinical significance relates to both cancer biology and aging; CDRT4 modulation represents a potential therapeutic target for anti-aging interventions through ROS control and senescence management 2.